6-chloro-N-(4-methoxybenzyl)pyridazin-3-amine, 95.0%, 1g

(Polystyrylmethyl)trimethylammonium Cyanoborohydride cross-linked with 10% DVB (30-50mesh) (2.6-3.0mmol/g)5g

(S)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 95.0%, 250mg

4-(4-Fluorophenyl)-3-thiosemicarbazide, 97.0%, 25g

4-Vinylbiphenyl, 98.0%, 5g

(S)-METHYL 3-OXO-CYCLOPENTANECARBOXYLATE, 95.0%, 1g

2-Methyltetrahydrofuran (stabilized with BHT)>98.0%(GC)100mL

4,5,6,7-Tetrahydro-3H-imidazo[4,5-c]pyridine dihydrochloride, 95.0%, 10g

3-BROMO-6-FLUORO-2-METHYLBENZONITRILE, 95.0%, 250mg

Amisulpride>98.0%(HPLC)(T)1g

trans-3-Hexenedioic Acid>98.0%(T)5g

3-Fluoro-4-(trifluoromethyl)phenylacetic acid, 98.0%, 5g

4-Amino-1-methyl-3-(2-methylpropyl)-1H-pyrazole-5-carboxamide, 95%, 250mg